Machine Learning

Hyundai Motor Group and NVIDIA are expanding their partnership, aiming to dominate the future of autonomous vehicles with a data-driven, two-pronged strategy.

Aerospace tech firm Merlin lands on NASDAQ, securing capital to scale its AI-powered autonomous flight system for military and future civilian aircraft.

Lidar leader Hesai joins NVIDIA's accredited Halos lab, a move to standardize safety validation and build public trust in the future of autonomous vehicles.

As executives head to a key summit, all eyes are on OPENLANE's plan to navigate a used car market ripe with digital opportunity and economic risk.

A new partnership integrates NVIDIA's high-speed NVQLink, accelerating the race toward fault-tolerant, utility-scale quantum computers.

In a new partnership, ALS Network and ALS United are seeking innovative ideas to accelerate breakthroughs, offering fresh hope to the ALS community.

A new alliance aims to overhaul Alzheimer's research, demanding a precision approach for the 65% of patients carrying the high-risk APOE4 gene.

Challenging cloud giants, Ocean Network launches a beta to create a liquid, pay-per-use market for high-performance GPUs, targeting AI developers.

The new Bugcount analyzer promises lab-grade microbial results in minutes, challenging industry leaders with a rugged, data-integrated platform.

Private firm Top Aces will lead Argentina’s transition to F-16s, a key step in a major air force modernization with deep geopolitical implications.

A Hong Kong toy firm announces a massive 500 MW AI data center in Canada, raising questions about its expertise, strategy, and a curious insider connection.

While the IT market saw a modest recovery, D&H Distributing posted massive gains by empowering partners to capitalize on AI and advanced solutions.

As Cannabix rolls out its THC breathalyzer, a new tool emerges for employers and police. But can it truly distinguish recent use from impairment?

A new one-time gene therapy shows it can clear toxic brain plaques in preclinical studies, offering a potential path to halt or even reverse Alzheimer's.

In a bid to reshape the AI hardware market, Celestica and AMD are joining forces on an open-standards platform to compete with established players.

San Diego biotech elevates key execs as it advances its inflammation pipeline, backed by Sanofi and Lilly, into a competitive and high-stakes market.

Patients are asking AI for medical advice. A new strategy, GEO, helps doctors stay visible and trusted in the new era of generative search results.

A $20M investment fuels Chorus Intelligence's AI-driven police software, sparking debate over efficiency gains versus ethical and privacy concerns.

A new compound could make CAR-T cell therapy more durable and less costly, showing promise against both cancer and HIV in groundbreaking new research.

A landmark partnership between Realta Fusion and Kyoto Fusioneering merges American physics with Japanese engineering to accelerate the path to commercial fusion.